51 related articles for article (PubMed ID: 28539568)
1. Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.
Elgendy IY; Mahtta D; Pepine CJ
Circ Res; 2019 May; 124(11):1520-1535. PubMed ID: 31120824
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers.
Borovac JA; D'Amario D; Bozic J; Glavas D
World J Cardiol; 2020 Aug; 12(8):373-408. PubMed ID: 32879702
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
Guay CA; Morin-Thibault LV; Bonnet S; Lacasse Y; Lambert C; Lega JC; Provencher S
PLoS One; 2018; 13(10):e0204610. PubMed ID: 30307953
[TBL] [Abstract][Full Text] [Related]
4. Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.
Chen Y; Wang H; Lu Y; Huang X; Liao Y; Bin J
BMC Med; 2015 Jan; 13():10. PubMed ID: 25598008
[TBL] [Abstract][Full Text] [Related]
5. Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes: a meta-analysis of five randomized controlled trials.
Wang G; Zhao Z; Zhao S; Ding S; Shen S; Wang L
J Interv Card Electrophysiol; 2015 Oct; 44(1):71-9. PubMed ID: 26162538
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Hemodynamic Effects of Endothelin Receptor Antagonists in Patients With Heart Failure.
Xiong B; Nie D; Cao Y; Zou Y; Yao Y; Tan J; Qian J; Rong S; Wang C; Huang J
Int Heart J; 2017 May; 58(3):400-408. PubMed ID: 28539568
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials.
Hwang IC; Kim YJ; Park JB; Yoon YE; Lee SP; Kim HK; Cho GY; Sohn DW
BMC Cardiovasc Disord; 2017 Jun; 17(1):150. PubMed ID: 28606099
[TBL] [Abstract][Full Text] [Related]
8. The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.
Xiong B; Huang Y; Tan J; Yao Y; Wang C; Qian J; Rong S; Deng S; Cao Y; Zou Y; Huang J
Heart Fail Rev; 2015 Nov; 20(6):633-42. PubMed ID: 26334632
[TBL] [Abstract][Full Text] [Related]
9. Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta-Analysis of 4894 Patients From 24 Randomized Double-Blind Placebo-Controlled Clinical Trials.
Wei A; Gu Z; Li J; Liu X; Wu X; Han Y; Pu J
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912207
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
